Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
JAMA|November 6, 1991
Prospective study of tardive dyskinesia incidence in the elderlyB L Saltz, M G Woerner, J M Kane, et al.
Diseases of the Colon and Rectum|March 27, 2004
Neuroendocrine carcinomas of the colon and rectumP E Bernick, D S Klimstra, J Shia, et al.
Diseases of the Colon and Rectum|May 1, 1997
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancerA Grann, B D Minsky, A M Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicinG K Schwartz, D Ward, L Saltz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1997
Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancerB D Minsky, A M Cohen, W E Enker, et al.
European Journal of Radiology|October 24, 2012
Goblet cell carcinoid neoplasm of the appendix: clinical and CT featuresK S Lee, L H Tang, J Shia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2015
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†L A Renfro, A Grothey, D Kerr, et al.
Schizophrenia Research|September 21, 2005
Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trialDel D Miller, Joseph P McEvoy, Sonia M Davis, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2008
Extrapyramidal side-effects of antipsychotics in a randomised trialDel D Miller, Stanley N Caroff, Sonia M Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2023
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trialsJ Taieb, F A Sinicrope, L Pederson, et al.
Pageof 8